Interferon β1a and depression in secondary progressive MS: Data from the SPECTRIMS Trial
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Depression is a suspected side effect of treatment with interferon beta1a in MS. However, an association with depression has not been confirmed by rigorous studies. During the SPECTRIMS clinical trial of interferon beta1a (Rebif) in secondary progressive MS, depression ratings were obtained from 365 subjects treated either with interferon beta1a or with placebo. No significant differences between groups emerged during 36 months of follow-up. These data suggest that depression is not a side effect of interferon beta1a.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1985) · American Journal of Psychiatry · doi:10.1176/ajp.142.5.559 · Cited by 1,723
Kappos, L. (1998) · The Lancet · doi:10.1016/s0140-6736(98)10039-9 · Cited by 936
Cited by
Depression in multiple sclerosis: a review
Siegert, R. J. (2005) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2004.054635 · Cited by 718
Major depression in multiple sclerosis: A population-based perspective
Patten, S. B., Beck, C. A., Williams, J. V. A., Barbui, C., & Metz, L. M. (2003) · Neurology · doi:10.1212/01.wnl.0000095964.34294.b4 · Cited by 529
Self-citationDepression and Chronic Medical Illness
Sachdeva, S., Cohen, D., Singh, A. K., Kaul, P., & Schwartz, T. L. (2009) · Medical Psychiatry · doi:10.3109/9781420084887.012 · Cited by 496
The Goldman Consensus statement on depression in multiple sclerosis
Goldman Consensus Group (2005) · Multiple Sclerosis Journal · doi:10.1191/1352458505ms1162oa · Cited by 329
Depression in multiple sclerosis
Patten, S. B., Marrie, R. A., & Carta, M. G. (2017) · International Review of Psychiatry · doi:10.1080/09540261.2017.1322555 · Cited by 262
“However, subsequent studies have failed to confirm an association in MS (Feinstein, O’Connor, & Feinstein, 2002; Patten & Metz, 2001, 2002; Schippling et al., 2016; Zephir et al., 2003).”
ResultSelf-citation
Metadata
- Authors
- Patten, S. B., & Metz, L. M.
- Venue
- Neurology
- Published
- 2002-09-10
- Volume
- 59
- Issue
- 5
- Pages
- 744-746
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- OpenAlex
- W2117855174
- Cited by
- 82
- References
- 2
- FWCI
- 4.77
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Interferon β1a and depression in secondary progressive MS: Data from the SPECTRIMS Trial. https://app.cochat.ai/papers/10.1212/wnl.59.5.744
- The paper
- Patten, S. B., & Metz, L. M. (2002). Interferon β1a and depression in secondary progressive MS: Data from the SPECTRIMS Trial. Neurology. https://doi.org/10.1212/wnl.59.5.744
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.